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Edited by Horst FeldmannAbstract PSF (PTB-associated splicing factor) is a multi-func-
tional protein that participates in transcription and RNA pro-
cessing. While phosphorylation of PSF has been shown to be
important for some functions, the sites and the kinases involved
are not well understood. Although PSF does not contain a typical
RS domain, we report here that PSF is phosphorylated in vivo to
generate an epitope(s) that can be recognized by a monoclonal
antibody speciﬁc for phosphorylated RS motifs within SR pro-
teins. PSF can be phosphorylated by human and yeast SR ki-
nases in vivo and in vitro at an isolated RS motif within its N
terminus. A functional consequence of SR phosphorylation of
PSF is to inhibit its binding to the 3 0 polypyrimidine tract
of pre-mRNA. These results indicate that PSF is a substrate
of SR kinases whose phosphorylation regulates its RNA binding
capacity and ultimate biological function.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The removal of intervening sequences (introns) from pre-
mRNA (splicing) is catalyzed by the spliceosome. The forma-
tion of the spliceosome happens in a stepwise manner via the
organization of small ribonucleoproteins (snRNPs), U1, U2,
U4/U6 and U5 and non-snRNP proteins. Following U1
snRNP association with the 5 0 splice site, SF1 and U2AF65
cooperatively bind to the branch point and polypyrimidine
tract (Py) to recruit U2snRNP to form the A complex. The
incorporation of tri-snRNPs, U4/U6.U5 is followed by splice-
osome rearrangement to form the catalytic center, C complex
[1,2]. In higher eukaryotes, the Py of the 3 0 splice site is highly
conserved and recognized by several proteins, including
U2AF65 and PSF [1,3]. U2AF65, a member of the SR family
[4], through recognition of the branch point and Py, can recruit*Corresponding author. Fax: +1 512 475 7707.
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doi:10.1016/j.febslet.2006.12.015U2 snRNA to base-pair with the branch sequence [3]. PSF is a
100 kDa protein, which was originally co-puriﬁed with Py
binding protein (PTB) [5]. Subsequently, Patton et al. [6] found
that PSF, but not PTB, could interact with the Py indepen-
dently.
Several lines of evidence have shown that PSF is a multi-
functional protein [7]. PSF is generally isolated in a complex
[8] with a similar, multifunctional RNP protein, p54nrb/nonO
[9,10]. Both proteins contain the DBHS (Drosophila Behavior;
Human Splicing) domain, a region present in several other
proteins that function in quite diﬀerent ways to regulate gene
expression [7,9,11]. In addition to its Py binding, PSF as a
complex with p54nrb/nonO, binds to U5snRNA, indicating a
role in spliceosome formation [12]. Its association with U4/
U6.U5 tri-snRNP [12,13] further indicates that PSF partici-
pates in the second catalytic step of splicing [14]. Transcription
and pre-mRNA splicing are coupled by the C-terminal domain
(CTD) of RNA polymerase II [15]. PSF and p54nrb/nonO bind
strongly to both the hypo- or hyper-phosphorylated forms of
the CTD in vivo and in vitro [16]. Strong transcriptional acti-
vators enhance levels of splicing and 3 0-end cleavage, and this
stimulation requires the CTD [17]. PSF but not p54nrb/nonO
preferentially binds to strong activation domains to mediate
transcriptional activator- and CTD-dependent stimulation of
pre-mRNA processing [18]. As further evidence for a function
in transcriptional initiation, PSF forms a ternary complex with
the DNA-binding domains of several nuclear hormone recep-
tors and with Sin3A to recruit class I histone deacetylases
(HDACs) for repression [19]. Similarly, PSF and p54nrb/nonO
interact with the steroidogenic factor (SF-1) to recruit Sin3A
and HDACs to a repressive complex on the human CYP17
promoter [20]. In addition to these eﬀects on splicing and tran-
scription, the PSF-p54nrb/nonO complex appears to function
as a double-stranded break rejoining factor [21]. PSF and
p54nrb/nonO have been identiﬁed as components of a nuclear
RNA retention complex for regulating late expression of poly-
oma RNAs [22]. Finally, PSF binding to a cis-acting regula-
tory element (INS) within Human Immunodeﬁciency Virus
type I (HIV-1) gag/pol and env mRNAs leads to the degrada-
tion of INS-containing mRNA, whereas binding of p54nrb/
nonO to the INS leads to nuclear export of INS-mRNAs into
the cytoplasm [23].
The serine/arginine-rich proteins (SR proteins) are a highly
conserved family and play roles in both constitutive and alter-
native pre-mRNA splicing [4]. Typically, SR proteins containblished by Elsevier B.V. All rights reserved.
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domain at the carboxyl-terminus. SR proteins can be exten-
sively phosphorylated by kinases of the SRPK and Clk fami-
lies [24] as well as by topoisomerase I [25]. RS
phosphorylation occurs exclusively on serines within the RS
motif. ‘‘Non-typical’’ RS substrates which lack a deﬁned RS
domain have not been reported in mammalian cells. However,
in yeast, the RGG-containing, RS tract-devoid RNA binding
protein, Npl3, has been conﬁrmed as a substrate for the SR ki-
nase, Sky1 in vivo and in vitro [26,27]. Not only do SR kinases
have high speciﬁcity for their substrate proteins, but they also
show preference toward certain RS context. Wang et al. [28]
showed that SRPK2 has a stringent preference for RS dipep-
tides, and the consensus may be used to predict potential phos-
phorylation sites in candidate RS domain-containing proteins.
The degree of SR phosphorylation can regulate subcellular
localization, protein–protein interactions and the splicing reac-
tion itself [29]. SR proteins are well known to coordinate pro-
tein–protein interactions by their RS domain and recruit other
components of splicing [30]. For example, SR proteins interact
with exonic splicing enhancer (ESE) sequences [29] and with
the intronic branchpoint [31]. RS domains are required for ma-
ture spliceosome assembly [31,32], for recruiting the U4/U6.U5
tri-snRNP into the spliceosome [33,34], and for the second cat-
alytic step of splicing [35]. In general, SR proteins have been
shown to participate throughout the splicing reaction mediat-
ing both protein–RNA and direct RNA contacts. Simulta-
neous collaboration of multiple SR proteins may be required
to remove a single intron [35,36].
Both PSF and p54nrb/nonO are phospho-proteins [37–40].
Tyrosine-phosphorylated PSF and p54nrb/nonO have been
puriﬁed from the nuclear envelope of neuroblastoma cells,
but the functional consequences were not investigated [37].
PSF and p54nrb can be phosphorylated in vitro by protein ki-
nase C (PKC) [38,39]. While this appeared to enhance PSF’s
non-speciﬁc binding to DNA in vitro, no in vivo conﬁrmation
was provided [38]. Hyperphosphorylation of N-terminal ser-
ine/thronine residues in PSF was reported to alter its pro-
tein–protein interactions, but neither the kinase nor
mechanism was identiﬁed [40].
Neither PSF nor p54nrb/nonO contains prototypic RS tracts,
but both contain scattered RS dipeptides. The participation of
these two proteins in RNA processing and their multi-func-
tional similarities to SR proteins prompted us to address this
issue experimentally. Here we show that PSF can be phosphor-
ylated in vivo to induce the formation of an epitope that can be
recognized by an anti-SR antibody. PSF, but not p54nrb/nonO,
can be phosphorylated in vitro by SR kinases, SRPK1 and
DSK1 at an RS site within the N-terminus. SR phosphoryla-
tion of PSF inhibits its binding to the polypyrimidine tract
of pre-mRNA introns. These results indicate that PSF is an
unconventional substrate of SR kinases whose phosphoryla-
tion regulates its binding activity and its ultimate function in
pre-mRNA splicing.2. Materials and methods
2.1. Plasmid constructions
The cloning of full-length pET15b-PSF is described elsewhere [6].
PSF truncations (1–18, 28–47, 253–272, 331–350 and 400–419) were
cloned into pGEX (Amersham) separately, and their inserts wereampliﬁed by the polymerase chain reaction (PCR) using pfu DNA
polymerase (Stratagene). PCR fragments were cloned into BamHI
and EcoRI sites of the vector separately. The ORF of ASF/SF2 was
ampliﬁed by PCR using pfu DNA polymerase (Stratagene), and the
ampliﬁed ASF/SF2 PCR fragment was subcloned into the BamHI
and XhoI sites of pTrcHis (Invitrogen). pTrcHis-nonO was cloned
by the same strategy. To clone pET29a-Dsk1, Dsk1 was ampliﬁed
by PCR. The PCR product was digested with BamHI and XhoI and
then subcloned into pET29a (Novagen). pRSETb-SRPK1 was a gen-
erous gift of Xiang-Dong Fu (University Of California, San Diego).
p54nrb was obtained from Dr. Krainer (Cold Spring Harbor Laborato-
ries). Glutathione-S-transferase (GST) plasmid is a commercial product
(Amersham). To clone pCR3.1 Æ PSF and pCR3.1-PSF (HA), the ORF
of PSF was cloned into pCR3.1 (Invitrogen). Then, an HA tag was
created at the 3 0 end of the ORF of PSF.
2.2. In vitro phosphorylation assay
Protein substrates were puriﬁed and separately incubated at 1 lM
with puriﬁed SRPK1, 0.5 lM, or Dsk1, 0.5 lM, in a total volume of
20 ll containing a kinase buﬀer (50 mM Tris–HCl buﬀer, pH7.4,
10 mM MgCl2, 1 mM dithiothreitol) in the presence of 50 lM ATP
and 2 lCi of [ -32P] ATP at 23 C for 30 min. The reaction was termi-
nated by boiling in SDS–PAGE sample loading buﬀer. Samples were
fractionated on an 8% or a 12.5% SDS–polyacrylamide gel, and pro-
tein phosphorylation was detected by autoradiography [41].
2.3. Puriﬁcation of recombinant proteins
SRPK1, Dsk1, and putative substrates (nonO, p54nrb, PSF, and
ASF/SF2) were each expressed as N-terminally, 3XHis-tagged pro-
teins. Bacterial strains of interest were grown to an OD600 of 0.5–0.7
at 37 C in LB containing ampicillin, kanamycin or both. Cultures
were induced with IPTG. The harvested cells were washed with PBS
and resuspended in HKI buﬀer [42] and sonicated. The lysate was cen-
trifuged at 5000 rpm for 25 min in an HS4 rotor (Sovall) to separate
supernatant and cell debris. The supernatant was incubated with Ni-
NTA beads (Qiagen) for 1.5 h at 4 C. The beads were spun down
and washed three times with HKI buﬀer. The proteins were eluted with
HKI buﬀer containing 250 mM imidazole. Puriﬁed proteins were dia-
lyzed against buﬀer D (20 mM HEPES–KCl [pH 7.9], 100 mM KCl,
0.2 mM EDTA, 20% glycerol (v/v), protease inhibitors) before being
aliquoted and frozen at 70 C. Strains expressing GST-fusion pro-
teins were cultured and induced in the same manner, but puriﬁed on
glutathione-agarose beads in HKE buﬀer [42] with 5 mM of reduced
glutathione.
Bacterial co-transformation was performed as described elsewhere
[43]. Brieﬂy, proteins of interest were constructed with 6xHis-tagged
vectors (ampicillin resistant), where as the kinase, pET29a-Dsk1
(kanamycin-resistant) or pET29a-SRPK1 lacked the 6xHis-tag. Fol-
lowing drug selection and minidigest-conﬁrmation of co-transformed
single colonies, the His-tagged proteins were puriﬁed on Ni-NTA
beads as described earlier.
2.4. Expression of PSF in insect cells
To express PSF in insect sf21 cells, a SalI-XhoI fragment, containing
the full-length ORF of PSF was ligated into the SalI-XhoI sites of the
transfer vector, pFASTBACHTc (Gibco, BRL). Dsk1 was cloned into
the transfer vector, pFASTBAC, using the same strategy. Recombi-
nant viral DNA was generated with the BAC-To-BAC HT Expression
System (Gibco, BRL) according to the manufacturer’s instructions.
Recombinant viral DNAs were transfected into sf21 cells by using
Cellfectin (Gibco, BRL). Supernatants of transfected cultured cells
were collected as recombinant virus stocks. Large-scale infections were
performed by infecting 100 ml of sf21 cells (106/ml) in ﬂasks with the
virus stock of either PSF alone or PSF with Dsk1. The cells were har-
vested after 48–72 h of infection. PSF protein was puriﬁed by virtue of
its His-tag protein as described above.2.5. Antibodies
For anti-PSF antisera, full-length PSF with 6xHis was puriﬁed from
Escherichia coli and used for immunizing a rabbit. The rabbit blood
was collected six weeks following initial injection and two boosts. Der-
ivation of the SR phosphorylation-speciﬁc monoclonal antibody,
mAb3C5 was described elsewhere [41,44,45] and was generously pro-
vided as ascites ﬂuid by Dr. Turner (University of Birmingham, Bir-
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purchased from Roche Molecular Biochemicals. The strain of
mAb104 [46] was obtained from ATCC. The supernatant of mAb104
cell culture was used without dilution.
2.6. Transient transfection and immunoprecipitation
COS-7 cells were transfected by lipofectin using FuGene6 (Roche
Molecular Biochemicals) according to manufacturer’s recommenda-
tions. One hundred microliters of serum-free DMEM (GibcoBRL)
was added into 3 ll of FuGene6 tranfection reagent drop-by-drop
and incubated at room temperature for 5 min. The diluted FuGene6
transfectin reagent was then added to 1 lg of cDNA drop-by-drop
and incubated at room temperature for 15 min. The resultant Fu-
Gene-cDNA mixture was added to one 100 mm plate of COS-7 cells
with 2 ml of fresh medium. At 48 h post-transfection, the transfected
cells of each well were harvested and lysed with 150 ll of LOIPB buﬀer
(25 mM Tris Æ HCl [pH 7.8], 150 mM NaCl, 2 mM EDTA, 0.5% NP40
(v/v)). The lysates were spun and the supernatants were pre-cleared
with protein A beads. Four hundred microliters of the cell extracts
were incubated with 4 ll of anti-HA monoclonal antibody for an hour
at 4 C. Thirty microliters of protein A beads were added and incu-
bated at 4 C for 30 min. The bead complex was collected, washed
three times with LOIPB buﬀer, boiled in SDS sample buﬀer, and then
loaded onto a SDS–polyacrylamide gel. Protein samples were trans-
ferred to a PVDF membrane, and Western blots were performed using
mab3C5 and anti-PSF polyclonal antisera. Enhanced chemilumines-
cence (ECL) Western blotting (Amersham Corp.) was performed to
detect the protein samples as the manufacturers’ instructions.
2.7. RNA substrate preparation and in vitro RNA–protein gel shift
All RNA oligos were made by Oligo Therapeutics Inc. Synthesized
RNA oligos, b/p + Py (NT4) (5 0-UGCUGACCCUGUCCCUU-
UUUUUUCCACAGCUCG), which contains branch sequence (b/p)
(UGCUGAC) and polypyrimidine tract (Py) (CCCUUUUUUUU),
and scrambled branch sequence (NT3) (AUGCCCAUCGACCUC-
AAUAAU), were kinased with [c-32P] ATP for 45 min. The samples
were mixed with RNA loading buﬀer (98% formamide, 10 mM EDTA,
0.1% xylene cyanol (v/v), 0.1% bromophenol blue (v/v)), and loadedFig. 1. PSF can be recognized by SR phosphorylation-speciﬁc mAb 3C5 in
(pCR3.1 Æ PSF) or the empty expression vector (mock) was transiently transf
were collected and immunoprecipitated with an anti-HA monoclonal antibod
membrane, and then western blotting was performed with anti-PSF (a) or mA
of the anti-mouse secondary antibody against heavy and light immunoglobuonto a urea–6% polyacrylamide gel. Puriﬁed labeled oligos were eluted
and ethanol precipitated. Diﬀerent concentrations of protein (0.5–
2 lM) were incubated with radio-labeled RNA oligos (1 ng) in bind-
ing buﬀer, 20 mM HEPES–KCl [pH 7.9], 100 mM KCl, 1 mM DTT,
1 U/ll ribonuclease (RNase) inhibitor (Life Technologies), 0.2 mM
EDTA, 0.5 mg/ml tRNA and protease inhibitors (Roche Molecular
Biochemicals) for 25 min at 30 C. Radiolabeled RNA–protein com-
plexes were analyzed on 0.5· TBE 6% native polyacrylamide gels [47].3. Results
3.1. PSF expressed in mammalian cells was recognized by
phospho-RS speciﬁc antibody
To test whether PSF is phosphorylated by SR kinases, we
ﬁrst expressed the protein in COS-7 monkey kidney cells and
asked whether the expressed protein could be recognized by
phospho-RS speciﬁc antibodies such as mAb3C5 [41,44]. The
full-length cDNA of human PSF was cloned into a mamma-
lian cell expression vector, pCR3.1, which utilizes a CMV pro-
moter for ectopic over-expression. An HA tag was inserted at
the C terminus of the PSF ORF (pCR3.1 Æ PSF-HA) for immu-
noprecipitation purposes. Either PCR3.1, pCR3.1 Æ PSF or
pCR3.1 Æ PSF-HA was transiently transfected into Cos-7 cells.
After 48 h, whole cell lysates were prepared and subjected to
anti-HA immunoprecipitation followed by Western blotting.
In the lysates of pCR3.1 Æ PSF-HA -transfected cells, PSF-
HA is recognized by both anti-PSF (Fig. 1a, lane 3) and
mAb3C5 (Fig. 1b, lane 2), whereas no protein is recognized
by either antibody in the lysates of mock-transfected cells
(Fig. 1a, lane 2; Fig. 1b, lane 1). To conﬁrm that the immuno-
precipitation was speciﬁc for the HA-tag, we included the ly-
sates of untagged pCR3.1 Æ PSF-transfected cells in themammalian cells. HA-tagged PSF (pCR3.1 Æ PSF-HA), untagged PSF
ected into Cos-7 cells. After 48 h, supernatants from whole cell lysates
y. Samples were resolved on 10% SDS–PAGE, transferred to a PVDF
b 3C5 (b). Bands at 50 and 25 kDa in all samples result from reaction
lin chains.
226 C.-J. Huang et al. / FEBS Letters 581 (2007) 223–232Western blotting against anti-PSF. No band was detected in
this sample (Fig. 1a, lane 1). These results indicate that an epi-
tope is created on PSF expressed in mammalian cells that is
recognized by a monoclonal antibody that is speciﬁc for phos-
phorylated RS motifs.
3.2. SR kinases are suﬃcient to phosphorylate PSF in E. coli
Since PSF was recognized by phospho-RS speciﬁc antibody
in mammalian cells, we decided to test in bacteria whether a
prototypic SR protein kinase is necessary and suﬃcient (in
the absence of other eukaryotic-speciﬁc co-factors) to phos-
phorylate PSF. Full-length His-tagged versions of PSF, ASF/
SF2, and nonO were separately transformed and expressed
in E. coli either alone or together with Dsk1 or its human
orthologue, SRPK1 (PSFD or PSFS, respectively, in Fig. 2a
and b). The proteins were puriﬁed and then tested by Western
blotting with mAb3C5. The prototypic RS protein, ASF/SF2,
when co-expressed with Dsk1, was strongly recognized by
mAb3C5 (Fig. 2a, lane 7), indicating that no other eukaryotic
components were required. Likewise, PSF, co-expressed with
either Dsk1 (PSFD, Fig. 2a and b, lane 5) or with SRPK1Fig. 2. PSF co-expressed with SR kinases in bacteria can be recognized by S
proteins (nonO, PSF or ASF/SF2) or the same proteins co-expressed with D
transferred to PVDF membranes, and then western blotted with mAb3C5. (b
SRPK1 (PSFS) were separated as above and ﬁlters were blotted with anti-PSF
proteolytic fragment of PSF previously observed at high abundance [14].(PSFS, Fig. 2b, lane 6) was bound by mAb3C5, whereas PSF
expressed alone was not (Fig. 2a and b, lane 4). On the other
hand, p54nrb and nonO did not react with the SR phosphory-
lation-speciﬁc mAb3C5 when co-expressed with the kinase
(Fig 2a, lane 3 and data not shown).
Our results indicate that in E coli, SRPK1 or Dsk1 is suﬃ-
cient to create a phospho-epitope(s) for PSF that can be recog-
nized by mAb3C5. However, we observed signiﬁcantly reduced
intensity for PSF relative to ASF/SF2 (Fig. 2a) under condi-
tions of equal protein loading (data not shown). This indicates
that the interaction between PSFD and this monoclonal anti-
body is weaker than that of ASF/SF2. This result might reﬂect
the scarcity of reactive RS dipeptides within PSF or that the
fraction of PSF phosphorylated is less. The faster migrating
band of PSF of 68 kD, which was routinely recognized by both
anti-PSF and mAb3C5 (Fig. 2b and re-addressed below), is
very likely a N-terminal-containing, proteolytically-truncated
form of the same size that was previously reported in mamma-
lian cells [14].
Taken with the results of Fig. 1, PSF appears to be a
substrate for the SR kinases, Dsk1 and SRPK1, and theR phosphorylation-speciﬁc mAb3C5. (a) 2 lM of GST, or His-tagged
sk1 (nonOD, PSFD or ASF/SF2D) were resolved by 10% SDS–PAGE,
) 2 lM of puriﬁed PSF alone or PSF co-expressed with Dsk1 (PSFD) or
(left panel) or mAb3C5 (right panel). The reactive species at 68 kD is a
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similar to that found in conventional SR proteins.3.3. PSF is phosphorylated by SRPK1 and Dsk1 in vitro
SR proteins are phosphorylated by human SRPK1 and ﬁs-
sion yeast Dsk1 in a highly speciﬁc manner [4,41]. To deter-
mine whether PSF is a substrate of these two SR kinases, we
performed in vitro phosphorylation assays. SRPK1 or Dsk1Fig. 3. In vitro phosphorylation of PSF by SRPK1 or Dsk1. 1 lM of the i
incubated with 0.5 lM Dsk1 (a) or with the same concentration of SRPK1
resolved by 10% SDS–PAGE and visualized by phosphoimaging. Positionswas incubated with PSF, ASF/SF2, nonO or GST proteins
separately. As with the conventional substrate ASF/SF2
(Fig. 3a and b, lane 7), we found that PSF can be phosphory-
lated by either Dsk1 (Fig. 3a, lane 5) or SRPK1 (Fig. 3b, lane
5), albeit to a lesser extent. NonO and its human orthologue
p54nrb share high sequence identity with PSF, including an
RSR tripeptide motif immediately N-terminal to the RRMs.
However, neither nonO (Fig. 3a and b, lane 3) nor p54nrb (data
not shown) was phosphorylated by SRPK1 or Dsk1.ndicated bacterially expressed and puriﬁed recombinant proteins were
(b) in the presence of [c-32P] ATP at 23 C for 30 min. Samples were
of phosphorylated PSF and autophosphorylated kinase are indicated.
Fig. 4. An N-terminal RS dipeptide within PSF is phosphorylated by SRPK1. (a) Amino acid sequences spanning the ﬁve RS dipeptides, the two
mutations of 7-RS-8 within the N-terminal (1–18) region (bold), and their relative positions within PSF. All peptides were expressed and puriﬁed as
GST fusion proteins. (b) The indicated bacterially expressed GST fusion proteins were incubated with SRPK1 in the presence of [c-32P] ATP at 23 C
for 30 min (right panel). Integrity and equal inputs for each fusion protein were conﬁrmed by Commassie staining (left panel). (c) Bacterially
expressed RS (1–18) wildtype and mutated peptides (left panel) were incubated with SRPK1 in the presence of [c-32P] ATP at 23 C for 30 min (right
panel). The samples were resolved on 10% SDS–PAGE and visualized by phosphoimaging. Asterisks denote degradation products of full-length PSF.
The apparent increase in signal of SRPK1-mediated phosphorylation in this experiment relative to that in Fig. 3b results from the use of a higher
speciﬁc activity 32P-ATP substrate.
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is constitutive and occurs prior to substrate protein phosphor-
ylation [41]. Autophosphorylation of SRPK1, on the other
hand, is concentration-dependent [24]. Thus, we suspect that
the 70 kDa band in lanes containing Dsk1 is autophosphor-
ylated Dsk1. We suspect that the 66 kDa band in lane 7 of
Fig. 3b, as well as the very faint equivalently-sized band in
other lanes that contain SRPK1, is either a bacterial contami-
nant, which accompanies SRPK1 puriﬁcation, or a degrada-
tion product of SRPK1 that is particularly stable in the
presence of the substrate ASF. Regardless, the results strongly
indicate that PSF, but not its highly similar partner, p54nrb/
nonO, is an in vitro substrate of both SR kinases.3.4. An isolated RS dipeptide near the N-terminus of PSF is the
target of SR phosphorylation
PSF does not contain a conventional RS domain [4], but it
contains ﬁve interspersed RS dipeptides. To test whether one
or more of these is a genuine RS dipeptide responsible for
the phosphorylation by SRPK1, we constructed GST-fusions
of regions spanning each RS dipeptide, then expressed and
puriﬁed each of them from E. coli (Fig. 4a). Only the N-termi-
nal fragment (residues 1–18) was phosphorylated above back-
ground levels (Fig. 4b). Mutation of the RS dipeptide (residues
7 and 8 to LG) within the N-terminal region eliminated
SRPK1 phosphorylation (Fig. 4c). That 7-RS-8 is the only site
of SR phosphorylation was conﬁrmed by the lack of reactivity
of mAb3C5 against truncation mutants (26–707 and 313–707)
that lack this region but contain all other RS dipeptide candi-
dates (data not shown). Thus, this isolated motif can convey
SR kinase substrate speciﬁcity and anti-SR antibody immuno-
logical speciﬁcity to PSF.Fig. 5. SR phosphorylation regulates the in vitro binding of PSF to
the polypyrimidine tract of the 3 0 splice site. (a) Speciﬁcity of PSF-
pyrimidine (py) tract binding. PSF expressed alone in and puriﬁed
from E. coli was incubated with a labeled RNA oligo (1 ng)
containing the branch point (bp) and py (bp + py) at 30 C for 25 min
(lanes 1–4). Speciﬁc (lanes 5–9) or non-speciﬁc (lanes 10–14) unlabeled
competitors were added at varying concentrations to the binding
reactions prior to resolution on a 6% native polyacrylamide gel and
visualization by phosphoimaging. (b) SR phosphorylation reduces
binding. PSF (lanes 1–4) or PSF co-expressed with Dsk1 (PSFD) (lanes
5–8) or SRPK1 (PSFS) (lanes 9–12) were incubated separately with the
labeled RNA bp + py-containing oligo (1 ng) at 30 C for 25 min.
Samples were resolved and visualized as in (a).3.5. SR phosphorylation reduces the binding of PSF to the
polypyrimidine tract
To test whether SR phosphorylation aﬀects the ability of
PSF to bind to its pre-mRNA target, we performed an
in vitro gel mobility shift assay. In Fig. 5a, bacterially pro-
duced non-phosphorylated PSF was incubated at increasing
concentrations with a radiolabeled RNA oligonucleotide con-
taining both the branch point and the Py (b/p + Py) from the
intron of the Adenovirus major late (Adml) transcript [47].
With puriﬁed bacterially expressed protein, the slower migrat-
ing, more intense species corresponds to full-length PSF, while
the lower species is likely the 68 kDa breakdown product of
Figs. 2b and 3 which was previously shown [14] to bind to
RNA. Both species show speciﬁc competition with cold
bp + Py but not with a scrambled sequence competitor, NT3.
Having established speciﬁcity, we then tested equivalent con-
centrations (as judged by Commassie staining of inputs; data
not shown) of non-phosphorylated and phosphorylated PSF
(produced in and puriﬁed from E. coli) in the same assay
(Fig. 5b). We found that PSF–RNA interaction was signiﬁ-
cantly reduced by SR-phosphorylation of PSF by either
Dsk1 or SRPK1.
While there is considerable degradation of full length PSF,
we have repeated this experiment several times with indepen-
dent preparations of phosphorylated and non-phosphorylated
PSF and obtained the same results (data not shown). If a de-
graded version of PSF was giving rise to the minor (faster
mobility) gel shifted band as suspected [14], this species showsthe same binding and competition behavior as the slower
mobility gel-shifted (presumably) full-length PSF-containing
RNA-complex. In bacteria, SR phosphorylation (as judged
by the data of Fig. 2) and other experiments (e.g., protein
yields following Ni-resin puriﬁcation; data not shown) appears
to stabilize PSF relative to the non-phosphorylated form.
Phosphorylated preparations of PSF undoubtedly contain
non-phosphorylated substrate. Therefore, we suspect that the
230 C.-J. Huang et al. / FEBS Letters 581 (2007) 223–232inhibitory eﬀects of SR-phosphorylation of PSF observed in
Fig. 5b are an underestimate. We conclude that SR-phosphor-
ylation of PSF regulates its ability to bind to the polypyrimi-
dine tract of pre-mRNA introns.4. Discussion
When over-expressed in mammalian cells, PSF appears to be
phosphorylated by an unidentiﬁed SR kinase, likely one of the
SRPK family, such that an SR phosphorylation-speciﬁc mono-
clonal antibody (mAb3C5) could recognize it. These results
were conﬁrmed with an additional anti-SR monoclonal anti-
body, mAb104, for PSF expressed by baculoviral infection of
insect cells (data not shown). We found that recombinant
SRPK1 or Dsk1, SR kinases shown to have high speciﬁcity
for their substrates [24,41], phosphorylate PSF in vitro. Fur-
thermore, PSF is a substrate for both SR kinases when co-ex-
pressed with them in bacteria, as evidenced by their
recognition with mAb3C5. On the other hand, neither nonO
nor its human homologue, p54nrb, which shares high sequence
identity/similarity with PSF, is phosphorylated under the same
conditions. These results provided strong evidence that PSF is
a non-classical substrate of SR kinases and that the phosphor-
ylation is speciﬁc for RS dipeptides [24,41]. This conclusion
was conﬁrmed by mutagenesis experiments that demonstrated
SR phosphorylation near the N-terminus at position 8.
PSF is an atypical SR substrate in that it contains no obvi-
ous RS domain. While unusual, this is not unprecedented. In
budding yeast, Npl3p was reported to be phosphorylated by
mammalian SRPK1 and by its yeast homolog Sky1 [26]. As
with Np13p, in which only 1 of 8 RS dipeptides was phosphor-
ylated [27], only 1 of 5 RS dipeptides was phosphorylated in
PSF by SRPK1. According to Wang et al. [28], a serine (posi-
tion 0) with arginines on both sides (positions 1 and +1), and
with an arginine in position 3, is the preferred substrate for
SR kinases [28]. In PSF, 7-RS-8 ﬁts the consensus precisely
(Fig. 4a), and this motif explains why only RS (1–18) was
phosphorylated by SRPK1. On the other hand, p54nrb/nonO
contains an RS dipeptide, RSR, just N-terminal to its RNA
recognition motif [9,10]. Perhaps, it cannot be phosphorylated
by SRPK1 because it lacks either an arginine at position 3 or
the other criterion of Wang et al. [28], a basic patch surround-
ing the targeted serine. We noted that the level of phosphory-
lation of the N-terminal, RS-containing fragment was weaker
than that observed for full-length PSF. We suspect that this
short fusion fragment might not be folded as natively as the
full-length protein. It is also possible that other SRPK1 con-
tacts presented in full-length PSF were lost in the deleted ver-
sion.
PSF is an hnRNP protein that associates with RNA and
snRNP complexes at multiple stages. For example, PSF binds
to both U5snRNA [12] and the U4/U6.U5 tri-snRNP [13].
Since PSF also accumulates in the spliceosome complex B
[6], it likely participates in bridging this complex with tri-
snRNP. PSF interacts with the 5 0 splice site [48], but in addi-
tion, appears to accumulate in complex C where it could par-
ticipate in the second step of catalysis [14]. Therefore, we felt it
would be informative to determine the eﬀects of SR phosphor-
ylation of PSF on RNA binding. To address this, we chose to
determine the functional consequence of SR phosphorylation
on the binding of PSF to the intronic polypyrimidine track(Py). We observed a signiﬁcant and speciﬁc reduction of Py
binding by phosphorylated PSF. This is similar to what was
observed for the non-conventional SR protein Np13, in which
phosphorylation decreased its association with poly (A)+ RNA
[35]. Our binding experiment of Fig. 5b indicates that the ex-
tent of phosphorylation correlates with the degree of inhibi-
tion. However, we cannot distinguish whether
phosphorylation eliminates binding completely or whether it
reduces binding aﬃnity, because the preparations of phosphor-
ylated PSF most probably contain unphosphorylated sub-
strate. The same caveat holds for the conclusions drawn on
Np13 [35]. In addition, it was shown that modulation of
Sky1-mediated SR phosphorylation of Np13 is required for
its proper nuclear localization [27].
SR phosphorylation of conventional substrates, such as
ASF/SF2, can alter their interactions with RNA or with other
proteins to aﬀect pre-mRNA processing and mRNA export
[49–51]. Indeed, a phosphorylation–dephosphorylation cycle
is necessary for splicing [52–54]. PSF has been shown in two-
hybrid assays to interact with protein phosphatase type 1
(PP1) [55]. Microcystin-LR inhibits PP1 and PP2A by irrevers-
ibly binding to their catalytic subunits, thereby blocking the
catalytic function of the spliceosome and the assembly of com-
plexes B and C [55]. Both these complexes have been shown to
contain PSF [6,14]. The ﬁnding that SRPK1 co-localizes in
speckles with the splicing factors SC35 and B1C8 [28] indicates
that an SR kinase, PSF, and a putative phosphatase capable of
reversing the reaction are present in the same place at the same
time. SR proteins have been reported in Drosophila for regulat-
ing alternative splicing and sex determination, and phosphor-
ylation by Doa, a LAMMER kinase, plays an important role
in this regulation [56].
While PSF can serve as a substrate for SRPK1, our data do
not address whether PSF is phosphorylated exclusively by
SRPK1 in mammalian cells. PSF was reported to be hyper-
phosphorylated on serine and threonine residues during apop-
tosis—an event that dissociates PSF from PTB, leading to
binding interactions with new partners [40]. It remains to be
determined whether diﬀerential phosphorylation of PSF plays
a role in these events. Further investigation is necessary to
determine additional functional consequences of unconven-
tional SR phosphorylation of PSF.
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